Journal Article Summary
The article examines deliberate self-harm and attempted suicide, a significant public health issue with a lifetime prevalence of about 3% to 5% in Europe and the USA. This topic is crucial because the rates of self-harm are rising, particularly among vulnerable groups such as women, young adults, and individuals with psychiatric disorders. Understanding the factors contributing to self-harm and the effectiveness of various treatment options is essential for improving patient outcomes and reducing the risk of suicide.
The authors conducted a systematic review of existing studies to evaluate the effectiveness and safety of different treatments for self-harm in adolescents and adults. They analyzed 19 systematic reviews, randomized controlled trials, and observational studies, focusing on various interventions, including cognitive therapy, dialectical behavioral therapy, and medication options. The findings indicated that no pharmaceutical treatments have been definitively proven to reduce the recurrence of self-harm, although flupentixol depot injections might help, despite potential side effects. Psychological treatments showed mixed results, with some therapies potentially alleviating depression and anxiety but not necessarily preventing future self-harm incidents.
The article acknowledges several limitations, including the unclear effectiveness of many treatments and the potential risks associated with certain medications, such as paroxetine, which may increase suicidal thoughts. Readers should be aware of these limitations and the importance of discussing any self-harm behaviors or mental health concerns with a healthcare professional. Engaging in open conversations about treatment options and safety measures can help individuals receive appropriate care and support tailored to their needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Soomro G Mustafa. Deliberate self-harm (and attempted suicide). BMJ Clinical Evidence 2008. PMID: 19445786. PMCID: PMC2907980.
Featured Pill Pals Product
Paroxetine 10 mg Tablets --- 30 Count --- Generic for Paxil --- Zydus Pharma
Paroxetine 10 mg Tablets — 30 Count — Generic for Paxil — Zydus Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
